
Amgen appoints senior VP and chief compliance officer
pharmafile | October 18, 2012 | Appointment | Business Services, Manufacturing and Production, Research and Development, Sales and Marketing | Amgen, Cynthia Patton
Amgen has announced the appointment of Cynthia Patton to senior vice president and chief compliance officer.
Patton will report to Robert Bradway, president and chief executive, and will be responsible for Amgen’s worldwide compliance and business ethics organisation. She succeeds Anna Richo, who has resigned from the company to join another global biopharmaceutical company as general counsel.
Patton joined Amgen in 2005, and was most recently a vice president in the Amgen law department with responsibility for commercial legal activities in the US. Previously, she served as the lead commercial lawyer for both the oncology and inflammation business units.
“Cynthia has more than 20 years of healthcare legal experience and a deep understanding of our business operations,” Bradway said. “Cynthia’s addition to Amgen’s leadership team will help us further our commitment to conduct business ethically and in compliance with the laws and regulations that govern our business and industry.”
Related Content

FDA approves Amgen’s Imdelltra for extensive-stage small cell lung cancer
Amgen has announced that the US Food and Drug Administration (FDA) has approved Imdelltra (tarlatamab-dlle) …

Amgen opens new biomanufacturing facility in Ohio, US
Amgen has announced that it has opened a new manufacturing site in Central Ohio, US. …

AstraZeneca and Amgen asthma drug shows positive results in Phase III trial
AstraZeneca and Amgen’s new tezepelumab drug for the treatment of severe asthma has shown superiority …






